dc.creator | Zorić, Bojana | |
dc.creator | Janković, Ljiljana | |
dc.creator | Kuzmanović-Pfićer, Jovana | |
dc.creator | Zidverc-Trajković, Jasna | |
dc.creator | Mijajlović, Milija | |
dc.creator | Stanimirović, Dragan | |
dc.date.accessioned | 2020-07-02T13:15:38Z | |
dc.date.available | 2020-07-02T13:15:38Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 0734-0664 | |
dc.identifier.uri | https://smile.stomf.bg.ac.rs/handle/123456789/2288 | |
dc.description.abstract | Background: Burning mouth syndrome (BMS) is an intraoral burning or dysaesthetic sensation, recurring daily for more than two hours during the period longer than 3 months. The objective was to evaluate and analyse the efficacy of serotonin reuptake inhibitor fluoxetine on psychological factors, as well as on pain in participants with BMS. Methods: In a 6-month study, 100 participants with primary and secondary BMS were divided into two groups-fluoxetine and control (placebo) and examined by the dentist and the neurologist. Depression and anxiety were estimated by Hamilton Scale for Depression (HAM-D) and Anxiety (HAM-A) and Beck Depression Inventory (BDI) and the pain intensity by visual analogue scale (VAS). Results: Mean age of the participants was 60.33 in fluoxetine group and 67.4 in control group. Most of the participants were female-74% in the fluoxetine and 78% in the control group. Statistical difference between the fluoxetine and the control group was found in HAM-D results (P lt .05). Values of other scales and VAS decreased significantly after the therapy in both groups (P lt .05). Conclusions: Our trial results indicate that fluoxetine therapy not only improves the psychological status of participants with BMS but also fluoxetine decreases the intensity of pain in these patients. | en |
dc.publisher | Wiley, Hoboken | |
dc.relation | info:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41008/RS// | |
dc.rights | restrictedAccess | |
dc.source | Gerodontology | |
dc.subject | burning mouth syndrome | en |
dc.subject | depression | en |
dc.subject | fluoxetine | en |
dc.subject | psychological factor | en |
dc.title | The efficacy of fluoxetine in BMS-A cross-over study | en |
dc.type | article | |
dc.rights.license | ARR | |
dcterms.abstract | Кузмановић-Пфићер, Јована; Зидверц-Трајковић, Јасна; Станимировић, Драган; Мијајловић, Милија; Јанковић, Љиљана; Зорић, Бојана; | |
dc.citation.volume | 35 | |
dc.citation.issue | 2 | |
dc.citation.spage | 123 | |
dc.citation.epage | 128 | |
dc.citation.other | 35(2): 123-128 | |
dc.citation.rank | M23 | |
dc.identifier.wos | 000431497900010 | |
dc.identifier.doi | 10.1111/ger.12332 | |
dc.identifier.pmid | 29575009 | |
dc.identifier.scopus | 2-s2.0-85044460400 | |
dc.type.version | publishedVersion | |